Medicare Enrolled
Dr. Mahmood Eisa, MD
Neurology · Valdosta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eisa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eisa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eisa
Dr. Mahmood Eisa is a neurology specialist in Valdosta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Eisa performed 950 Medicare services across 820 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eisa received a total of $20,604 from 78 pharmaceutical and/or device companies across 1042 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eisa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 29% volume in GA
$20,604 industry payments
Medicare Practice Summary
Medicare Utilization ↗950
Medicare services
Top 29% in GA for neurology
820
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $89 | $224 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
119 | $31 | $111 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
115 | $113 | $369 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $58 | $146 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
80 | $93 | $355 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
57 | $83 | $340 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 49 | $15 | $56 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
33 | $40 | $157 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $77 | $215 |
| Tilt table test for heart function A test that monitors heart function while the patient is moved from a lying to an upright position on a special table. |
17 | $89 | $337 |
| New patient office visit, complex (60-74 min) | 14 | $128 | $474 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $128 | $314 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,604
Total received (2018-2024)
Avg $2,943/year across 7 years
Top 16% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
1,042
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,195 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$409 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,655
2023
$3,763
2022
$2,613
2021
$3,069
2020
$2,034
2019
$2,721
2018
$1,751
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lundbeck LLC
$476
ABBVIE INC.
$458
UCB, Inc.
$343
Lilly USA, LLC
$306
Alexion Pharmaceuticals, Inc.
$261
SK Life Science, Inc.
$255
Neurocrine Biosciences, Inc.
$249
PFIZER INC.
$219
JAZZ PHARMACEUTICALS INC.
$189
CATALYST PHARMACEUTICALS, INC.
$188
Eisai Inc.
$180
Kyowa Kirin, Inc.
$158
Ipsen Biopharmaceuticals, Inc
$152
Otsuka America Pharmaceutical, Inc.
$141
Neurelis, Inc.
$141
Sumitomo Pharma America, Inc.
$136
Teva Pharmaceuticals USA, Inc.
$134
ANI Pharmaceuticals, Inc.
$98
Novartis Pharmaceuticals Corporation
$84
Grifols USA, LLC
$64
HARMONY BIOSCIENCES LLC
$58
Alnylam Pharmaceuticals Inc.
$58
E.R. Squibb & Sons, L.L.C.
$56
Genentech USA, Inc.
$42
Harmony Biosciences Llc
$36
CSL Behring
$35
Amneal Pharmaceuticals LLC
$30
GENZYME CORPORATION
$24
ARGENX US, INC.
$19
TG Therapeutics, Inc.
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$17
Mirum Pharmaceuticals, Inc.
$16
Amgen Inc.
$13
Top 3 companies account for 27.4% of 2024 payments
All-time payments by company (2018-2024) ›
SK Life Science, Inc.
$1,065
UCB, Inc.
$980
Lundbeck LLC
$978
ABBVIE INC.
$880
Teva Pharmaceuticals USA, Inc.
$840
Lilly USA, LLC
$699
Amgen Inc.
$696
Alexion Pharmaceuticals, Inc.
$647
Eisai Inc.
$604
Sunovion Pharmaceuticals Inc.
$584
Novartis Pharmaceuticals Corporation
$576
Neurelis, Inc.
$569
Kyowa Kirin, Inc.
$557
Neurocrine Biosciences, Inc.
$516
JAZZ PHARMACEUTICALS INC.
$510
Greenwich Biosciences, Inc.
$460
Ipsen Biopharmaceuticals, Inc
$457
GENZYME CORPORATION
$418
PFIZER INC.
$408
Avanir Pharmaceuticals, Inc.
$407
AbbVie Inc.
$340
Allergan Inc.
$327
Sumitomo Pharma America, Inc.
$318
Medtronic USA, Inc.
$307
Acorda Therapeutics, Inc
$295
Allergan, Inc.
$292
Harmony Biosciences LLC
$289
Genentech USA, Inc.
$284
Supernus Pharmaceuticals, Inc.
$281
Adamas Pharmaceuticals, Inc.
$272
CSL Behring
$270
EMD Serono, Inc.
$257
EISAI INC.
$251
Horizon Therapeutics plc
$227
IMPEL PHARMACEUTICALS INC.
$225
MITSUBISHI TANABE PHARMA AMERICA, INC.
$212
Biogen, Inc.
$201
CATALYST PHARMACEUTICALS, INC.
$201
ARGENX US, INC.
$201
ACADIA Pharmaceuticals Inc
$200
Otsuka America Pharmaceutical, Inc.
$190
Amneal Pharmaceuticals LLC
$147
Jazz Pharmaceuticals Inc.
$145
E.R. Squibb & Sons, L.L.C.
$144
Medtronic, Inc.
$137
Biohaven Pharmaceuticals, Inc.
$133
Merz North America, Inc.
$133
Alnylam Pharmaceuticals Inc.
$128
Grifols USA, LLC
$121
Merz Pharmaceuticals, LLC
$116
AbbVie, Inc.
$108
Almatica Pharma LLC
$100
ANI Pharmaceuticals, Inc.
$98
HARMONY BIOSCIENCES LLC
$73
Biohaven Pharmaceutical Holding Company Ltd.
$72
Catalyst Pharmaceuticals, Inc.
$63
IDORSIA PHARMACEUTICALS US INC
$58
Upsher-Smith Laboratories LLC
$54
Mitsubishi Tanabe Pharma America, Inc.
$47
Janssen Pharmaceuticals, Inc
$40
Impax Laboratories, Inc.
$38
Harmony Biosciences Llc
$36
Exeltis, USA Inc.
$34
Philips Electronics North America Corporation
$32
Promius Pharma LLC
$27
MDD US Operations, LLC
$26
Collegium Pharmaceutical, Inc.
$25
Alfasigma USA, Inc.
$24
MERZ NORTH AMERICA, INC.
$21
BOSTON SCIENTIFIC CORPORATION
$19
TG Therapeutics, Inc.
$18
Neuronetics, Inc.
$16
Mirum Pharmaceuticals, Inc.
$16
LivaNova USA, Inc.
$15
Scilex Pharmaceuticals Inc.
$14
GRT US Holding, Inc.
$13
Mallinckrodt Hospital Products Inc.
$11
Purdue Pharma L.P.
$11
Top 3 companies account for 14.7% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CREXONT · Cenobamate · Cholbam · DUOPA · DYSPORT · Duopa · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · Mavenclad · NAPRELAN · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · ONFI · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · REVEAL LINQ · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPROIC · Soliris · TECFIDERA · TEPEZZA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS Therapy · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XLSD · XTAMPZA · XYREM · XYWAV · Xembify · Xeomin · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
5
Per 100K population
4.2
County median income
$55,887
Nearest hospital
SGMC HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eisa is a clinical cardiology specialist, with above-average Medicare volume (top 29% in GA), with low-engagement industry engagement in the top 16% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eisa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Eisa performed 318 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eisa receive payments from pharmaceutical companies?
Yes. Dr. Eisa received a total of $20,604 from 78 companies across 1,042 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eisa's costs compare to other neurologists in Valdosta?
Dr. Eisa's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eisa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Valdosta
Browse neurologists in Valdosta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
SK Life Science, Inc. Payments to Doctors
See all physicians who received payments from SK Life Science, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Lundbeck LLC Payments to Doctors
See all physicians who received payments from Lundbeck LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology